ENZ Related Corporate News
-
Enzo Biochem (ENZ) Makes EarlyCDT-Lung by Enzo Clinical Labs Available
-
Enzo Biochem Inc. (ENZ) Expands Business Agreement with Cosmo Bio Co.
-
Enzo Biochem (ENZ) Gets NY DoH Approval for ColonSentry Test
-
Enzo Biochem (ENZ) Unit Updates on Sulfated Tyrosine
-
Enzo Biochem (ENZ) Unit Acquires Biomarker Quantification Test
-
Enzo Biochem (ENZ) Commences Optiquel Clinical
-
Enzo Biochem (ENZ) Gives Details on Plan to Streamline Operations; Sees $500K Charge for Severance, Sees Positive Operating Cash Flow in '11
-
Enzo Biochem (ENZ) Receives Approval to Conduct Business in Pennsylvania
-
Enzo Biochem (ENZ) Announces Agreement to Market MultiGEN's Diagnostic Tests In New York
-
Enzo Biochem (ENZ) Announces Agreement to Market MultiGEN's DNA Sequencing Diagnostic Test in New York
-
Enzo Biochem (ENZ) Receives Favorable Ruling in Patent Suit; Shares Jump
-
Enzo Biochem (ENZ) Receives Favorable Judgment by US Patent Office Related to Application for Nucleic Acid Signal Amplification
-
Enzo Biochem (ENZ) Issues Operational, Financial Update at Annual Meeting
-
Enzo Biochem (ENZ) Enters Cross-Licensing Agreements with Abbott
-
U.S. Patent Board Awards Enzo Biochem (ENZ) Judgment in Patent Interference after Princeton University Concedes Priority
-
Enzo Biochem (ENZ) Says Federal Court Issues Favorable Ruling Upholding Key Patent Claim Terms
-
Enzo Biochem (ENZ) Receives License to Comprehensive Non-PCR Based Amplification Technology
-
Enzo Biochem (ENZ) Subsidiary Selected as Regional Provider of Medical Laboratory Services for UnitedHealthcare (UNH)
-
Sigma-Aldrich (SIAL) Reaches Settlement with Enzo Biochem (ENZ)
-
Enzo Biochem (ENZ) Says US Patent Office Declares 2 Patent Interferences for Key Nucleic Acid Detection Technology
-
Judge Says Hundreds of Defendants' Products Infringe on Enzo Biochem's (ENZ) Patents
-
ENZ Receives Approval From CHR To Continue Clinical Evaluation of Stealth Vector
Back to ENZ Stock Lookup
